Question 1

Who are the top researchers at OncoImmune (United States)?

Accepted Answer

Ranked on the quality score, Akira Komoriya, Laura J. Peek and Beverly Z. Packard lead among researchers whose main affiliation is OncoImmune (United States).

Question 2

What are the most cited papers from OncoImmune (United States)?

Accepted Answer

The most cited paper from OncoImmune (United States) is "Lytic Granule Loading of CD8+ T Cells Is Required for HIV-Infected Cell Elimination Associated with Immune Control" (Stephen A. Migueles et al., 2008), with 612 citations. Next come "A reappraisal of CTLA-4 checkpoint blockade in cancer immunotherapy" (251) and "Audit of the autoantibody test, EarlyCDT®-Lung, in 1600 patients: An evaluation of its performance in routine clinical practice" (244).

Question 3

Which research topics does OncoImmune (United States) publish most on?

Accepted Answer

By volume in 2022-now: Immunotherapy and Immune Responses, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers and Advanced biosensing and bioanalysis techniques.

Question 4

Which keywords describe research at OncoImmune (United States)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Cancer Immunotherapy, Immunity, Immunotherapy, Innate Immunity, Antigen Presentation, Dendritic Cells, Tumor Antigen and Vaccine Adjuvants.

Question 5

Which fields of science does OncoImmune (United States) work in?

Accepted Answer

In 2022-now, 54% of research at OncoImmune (United States) is in Life Sciences, 37% in Health Sciences. Its largest fields are Medicine (37%), Biochemistry, Genetics and Molecular Biology (29%), Immunology and Microbiology (25%). It does 2.5× the world's share of Life Sciences.

Question 6

Is OncoImmune (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 24% higher than in 2018-2021.